Clinical trial
A Dynamic, Multiple-biomarker Approach Aiming for Individualized Treatment of Heart Failure With Preserved Ejection Fraction (ADAPT-HFpEF)
NCT06785506 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dynamic, Multiple-biomarker Approach Aiming for Individualized Treatment of Heart Failure With Preserved Ejection Fraction (ADAPT-HFpEF)
- Lead sponsor
- Erasmus Medical Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 25, 2022
- Completion date
- November 1, 2026
- Enrollment
- 200 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure, heart failure with preserved ejection fraction, heart failure, diastolic